Compare PTEN & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTEN | STVN |
|---|---|---|
| Founded | 1978 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Containers/Packaging |
| Sector | Energy | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.7B |
| IPO Year | 1995 | 2021 |
| Metric | PTEN | STVN |
|---|---|---|
| Price | $11.42 | $17.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 3 |
| Target Price | $10.80 | ★ $25.67 |
| AVG Volume (30 Days) | ★ 7.5M | 294.4K |
| Earning Date | 04-22-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.24% | 0.39% |
| EPS Growth | ★ 90.16 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,826,624,000.00 | N/A |
| Revenue This Year | N/A | $9.67 |
| Revenue Next Year | $4.34 | $9.99 |
| P/E Ratio | ★ N/A | $27.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.10 | $12.89 |
| 52 Week High | $13.08 | $28.00 |
| Indicator | PTEN | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 46.58 | 39.65 |
| Support Level | $11.02 | $13.58 |
| Resistance Level | $11.75 | $17.19 |
| Average True Range (ATR) | 0.57 | 0.82 |
| MACD | -0.08 | -0.25 |
| Stochastic Oscillator | 26.80 | 12.66 |
Patterson-UTI Energy Inc is a Texas based provider of drilling and completion services to oil and natural gas exploration and production companies, offering contract drilling, integrated well completion, directional drilling services, and specialized drill bit solutions. The Company operates through three segments: Drilling Services, Completion Services, and Drilling Products. Drilling Services includes contract and directional drilling, Completion Services generates maximum revenue and includes hydraulic fracturing and related support services, and Drilling Products includes the manufacturing and distribution of drill bits. The Company operates in the United States, Canada, Colombia, and Other Countries, with the majority of revenue coming from the United States.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.